skip to main content

New Medicine Service suitability — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModeratePatient Counselling and Pharmaceutical CareNew Medicine Service suitabilityGPhC CRA

A 59-year-old woman is prescribed apixaban for newly diagnosed AF after hospital discharge. She is anxious about bleeding and has several questions about missed doses and dental appointments. The pharmacy provides a commissioned New Medicine Service. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: A — Offer structured NMS support alongside anticoagulant counselling

A new anticoagulant is a high-risk medicine where structured follow-up can improve understanding, adherence and safety. NMS support is appropriate if eligibility and consent requirements are met. Initial counselling should cover bleeding, missed doses, interactions and when to seek medical advice. Stopping apixaban before dental work should be guided by the dentist or prescriber.

Reference: NHS New Medicine Service service specification; BNF Apixaban